Good morning, everyone. Another shiny day is unfolding here on the Pharmalot corporate campus, where we are bracing for a busy few hours that include a planning meeting with the official Pharmalot publisher which, of course, takes place amidst the usual frenzied routine. And so, no need to dilly dally with so much to do. Here are a few tidbits, meanwhile, to help you along. Hope you accomplish much today. Stay in touch...
Trial Comparing Paclitaxel And Abraxane Raises Questions (Pharma Times)
India Should Tax Airfare To Pay For AIDS Drugs: UN (Reuters)
Abbott Names Leadership Team For Abbvie (Dow Jones)
Merck KGgA And Dr. Reddy's Strike A Biosimilars Deal (Reuters)
Auxilium Reports Positive Results For Curved Penis Drug (Los Angeles Times)
European Union Embraces Track And Trace (New Europe)
FDA Wants More Tests For Merck Sarcoma Drug (Associated Press)
France Issues New Advertising Guidelines (Regulatory Focus)
Roche Says Arthritis Drug Beats Top-Selling Rival In Trial (Reuters)
Vivus Says No EU Ruling Qnexa Before September (Associated Press)
UK Drugmakers Issue Warning Over Pricing Talks (Reuters)
Abbvie To Keep Pharma CMO Biz After Abbott Spinoff (Outsourcing Pharma)
Abbott Looks To Grow Nutrition Business In India (MarketWatch)
Tylenol Recalls Leave Drugstores Short (Sacramento Bee)
EDITOR'S NOTE: Please check this post for updates during the day
sunrise pic thx to benimoto on flickr
1 Comment